REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H-Reference-Cited by-同舟云学术

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

Published:1988-12 Issue:8625 Volume:332 Page:1394-1399
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Hale G.,Clark M.R.,Marcus R.,Winter G.,Dyer M.J.S.,Phillips J.M.,Riechmann L.,Waldmann H.

Publisher

Elsevier BV

Subject

General Medicine

Reference17 articles.

1. Eighty years of immunotherapy: a review of immunological methods used for treatment of human cancer;Currie;Br J Cancer,1972

2. Removal of T cell from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement;Hale;Blood,1983

3. Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation;Hale;Br J Haematol,1985

4. Removal of T cells from bone marrow for transplantation: comparison of rat monoclonal anti-lymphocyte antibodies of different isotypes;Hale;Mol Biol Med,1983

5. Isolation of low-frequency class-switch variants from rat hybrid myelomas;Hale;J Immunol Meth,1987

Cited by 394 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells;Blood Advances;2024-08-30

2. Living in LALA land? Forty years of attenuating Fc effector functions;Immunological Reviews;2024-08-19

3. Alemtuzumab in renal transplantation. Reviews of literature and usage in the United Kingdom;Transplantation Reviews;2022-04

4. Low vitamin D levels do not predict risk of autoimmune disease following alemtuzumab treatment for multiple sclerosis;Multiple Sclerosis and Related Disorders;2022-03

5. Steroid‐free maintenance immunosuppression using alemtuzumab in pediatric kidney transplantation: Long‐term longitudinal follow‐up;Pediatric Transplantation;2021-10-23